Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Stratum corneum cohesion proteins” is not a single molecular target but refers collectively to several structural and adhesion proteins critical for the integrity of the stratum corneum, the outermost layer of the epidermis. Key proteins include corneodesmosin (CDSN), desmocollin 1 (DSC1), and desmoglein 1 (DSG1), which are integral components of *corneodesmosomes*—specialized cell junctions linking adjacent corneocytes and maintaining skin barrier cohesion. Their regulated degradation by specific serine proteases (KLK5, KLK7) enables controlled cell shedding (desquamation). Disruption or abnormal proteolysis of these proteins impairs barrier function and is associated with dermatological diseases, including atopic dermatitis and ichthyosis[1][7][3]. Since “stratum corneum cohesion proteins” does not correspond to a unique, singular target but rather a mixture of molecules, this entry is non-canonical and too general for structured database indexing[1][3][7].
Proteolysis by serine proteases (KLK5, KLK7) leads to degradation of adhesion proteins (e.g., corneodesmosin), reducing cohesion and allowing desquamation[1][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum cohesion protein.